Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR52 | Q9Y2T5 | 17/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3888975 | 1.00 | GPR52 (0.51) | GPR52 | |
| SCHEMBL9467164 | 1.00 | GPR52 (0.51) | GPR52 | |
| SCHEMBL3888969 | 1.00 | GPR52 (0.51) | GPR52 | |
| SCHEMBL451147 | 0.84 | GPR52 (0.47) | GPR52 | |
| SCHEMBL106720 | 0.84 | GPR52 (0.47) | GPR52 | |
| SCHEMBL8714626 | 0.80 | TDP1 (0.43) | GPR52 | |
| Hydrocinnamyl Alcohol SCHEMBL28865674 | 0.80 | CYP1A2 (0.49) | — | |
| SCHEMBL28556825 | 0.79 | GPR52 (0.47) | GPR52 | |
| SCHEMBL9356463 | 0.78 | GPR52 (0.53) | GPR52 | |
| SCHEMBL9356460 | 0.78 | GPR52 (0.53) | GPR52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5097734-A | — | — | None | — | — | JP | disclosed |
| US-8334405-B2 | Chiral thiourea compounds and process for enantioselective reduction of ketones | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-12-18 | — | — | US | disclosed |
| US-20090253919-A1 | Chiral thiourea compounds and process for enantioselective reduction of ketones | BOARD OF REGENTS (US) | 2009-10-08 | — | — | US | disclosed |
| JP-H0597734-A | ALLYL REARRANGEMENT OF ALLYL ALCOHOLS | SUMITOMO CHEM CO LTD | 1993-04-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253919-A1 | Chiral thiourea compounds and process for enantioselective reduction of ketones | TREH, ADH1A, ADH1C | GPR52 3860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.